HitGen Inc. (SHA:688222)
China · Delayed Price · Currency is CNY 24.89
+1.64 (7.05%)
At close: Mar 27, 2026
HitGen Market Cap
HitGen has a market cap or net worth of 9.94 billion as of March 27, 2026. Its market cap has increased by 46.67% in one year.
Market Cap
9.94B
Enterprise Value
9.19B
Revenue
525.57M
Ranking
n/a
PE Ratio
88.89
Stock Price
24.89
Market Cap Chart
Since April 16, 2020, HitGen's market cap has decreased from 18.86B to 9.94B, a decrease of -47.30%. That is a compound annual growth rate of -10.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 9.94B | 6.14% |
| Dec 31, 2025 | 9.37B | 90.34% |
| Dec 31, 2024 | 4.92B | -17.81% |
| Dec 29, 2023 | 5.99B | 10.86% |
| Dec 30, 2022 | 5.40B | -42.61% |
| Dec 31, 2021 | 9.41B | -22.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hualan Biological Vaccine | 11.41B |
| Aurisco Pharmaceutical | 10.84B |
| InventisBio | 10.36B |
| Jiangxi Fushine Pharmaceutical | 10.28B |
| Liaoning Chengda Biotechnology | 10.03B |
| Beijing Hotgen Biotech | 9.78B |
| Chongqing Genrix Biopharmaceutical | 9.57B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 9.51B |